Switch theme
Sign up to access all valuation multiples
OrganoClick AB is involved in the chemicals industry. Its product portfolio includes green chemical technologies for creating water repellency, biobased binders for increasing the mechanical strength, and wood treatment products for resistance to fungal degradation and resistance to fire. It operates in four business areas Functional Wood, Green coatings & maintenance products, Nonwoven & technical textile, and Other. The group has a single operating segment.
2006
40
LTM Revenue $13.4M
LTM EBITDA $0.7M
$28.0M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
OrganoClick has a last 12-month revenue (LTM) of $13.4M and a last 12-month EBITDA of $0.7M.
In the most recent fiscal year, OrganoClick achieved revenue of $13.1M and an EBITDA of $0.6M.
OrganoClick expects next 12-month revenue of XXX and NTM EBITDA of XXX
See OrganoClick valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $13.4M | XXX | $13.1M | XXX | XXX | XXX |
| Gross Profit | $3.4M | XXX | $3.3M | XXX | XXX | XXX |
| Gross Margin | 26% | XXX | 25% | XXX | XXX | XXX |
| EBITDA | $0.7M | XXX | $0.6M | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 4% | XXX | XXX | XXX |
| EBIT | -$0.9M | XXX | -$1.1M | XXX | XXX | XXX |
| EBIT Margin | -6% | XXX | -8% | XXX | XXX | XXX |
| Net Profit | -$1.6M | XXX | -$1.9M | XXX | XXX | XXX |
| Net Margin | -12% | XXX | -14% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $5.0M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, OrganoClick's stock price is SEK 2 (or $0).
OrganoClick has current market cap of SEK 196M (or $20.2M), and EV of SEK 271M (or $28.0M).
See OrganoClick trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $28.0M | $20.2M | XXX | XXX | XXX | XXX | $-0.02 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, OrganoClick has market cap of $20.2M and EV of $28.0M.
OrganoClick's trades at 2.1x EV/Revenue multiple, and 47.5x EV/EBITDA.
Equity research analysts estimate OrganoClick's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
OrganoClick has a P/E ratio of -12.3x.
See valuation multiples for OrganoClick and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $20.2M | XXX | $20.2M | XXX | XXX | XXX |
| EV (current) | $28.0M | XXX | $28.0M | XXX | XXX | XXX |
| EV/Revenue | 2.1x | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | 37.5x | XXX | 47.5x | XXX | XXX | XXX |
| EV/EBIT | -32.5x | XXX | -25.7x | XXX | XXX | XXX |
| EV/Gross Profit | 8.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | -12.3x | XXX | -10.9x | XXX | XXX | XXX |
| EV/FCF | -23.8x | XXX | -49.3x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialOrganoClick's last 12 month revenue growth is 11%
OrganoClick's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
OrganoClick's rule of 40 is 15% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
OrganoClick's rule of X is 32% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for OrganoClick and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 11% | XXX | 11% | XXX | XXX | XXX |
| EBITDA Margin | 6% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | 121% | XXX | 23% | XXX | XXX | XXX |
| Rule of 40 | 15% | XXX | 15% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 32% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 17% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 33% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
OrganoClick acquired XXX companies to date.
Last acquisition by OrganoClick was XXXXXXXX, XXXXX XXXXX XXXXXX . OrganoClick acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was OrganoClick founded? | OrganoClick was founded in 2006. |
| Where is OrganoClick headquartered? | OrganoClick is headquartered in Sweden. |
| How many employees does OrganoClick have? | As of today, OrganoClick has 40 employees. |
| Is OrganoClick publicy listed? | Yes, OrganoClick is a public company listed on STO. |
| What is the stock symbol of OrganoClick? | OrganoClick trades under ORGC ticker. |
| When did OrganoClick go public? | OrganoClick went public in 2015. |
| Who are competitors of OrganoClick? | Similar companies to OrganoClick include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of OrganoClick? | OrganoClick's current market cap is $20.2M |
| What is the current revenue of OrganoClick? | OrganoClick's last 12 months revenue is $13.4M. |
| What is the current revenue growth of OrganoClick? | OrganoClick revenue growth (NTM/LTM) is 11%. |
| What is the current EV/Revenue multiple of OrganoClick? | Current revenue multiple of OrganoClick is 2.1x. |
| Is OrganoClick profitable? | Yes, OrganoClick is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of OrganoClick? | OrganoClick's last 12 months EBITDA is $0.7M. |
| What is OrganoClick's EBITDA margin? | OrganoClick's last 12 months EBITDA margin is 6%. |
| What is the current EV/EBITDA multiple of OrganoClick? | Current EBITDA multiple of OrganoClick is 37.5x. |
| What is the current FCF of OrganoClick? | OrganoClick's last 12 months FCF is -$1.2M. |
| What is OrganoClick's FCF margin? | OrganoClick's last 12 months FCF margin is -9%. |
| What is the current EV/FCF multiple of OrganoClick? | Current FCF multiple of OrganoClick is -23.8x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
